Navigation Links
RAD001 Phase II Trial Results Positive in Patients with Advanced Gastric Cancer After Failure of One or More Prior Treatments
Date:1/13/2009

hat_are_the_key_statistics_for_stomach_cancer_40.asp?rnav=cri" target="_new">http://www.cancer.org/docroot/CRI/content/CRI_2_4_1X_What_are_the_key_statistics_for_stomach_cancer_40.asp?rnav=cri. Accessed on December 23, 2008.

(3) Ohtsu, A. Chemotherapy for metastatic gastric cancer: past, present, and future. J Gastroenterol 2008; 43:256-264.

(4) American Cancer Society. Overview: Stomach Cancer. Available at: http://www.cancer.org/docroot/CRI/content/CRI_2_2_2X_What_causes_stomach_cancer_40.asp?sitearea=. Accessed on December 23, 2008.

Novartis Media Relations

    Media only:                               Investors only:
    Denise Brashear                           Jill Pozarek
    Novartis Oncology                         Novartis Corporation
    P: +1 862 778 7336                        P: +1 212 830 2445
    F: +1 917 453 2665

    Dana Kahn Cooper
    P: +1 732 817 1800
    F: +1 732 817 1834


'/>"/>
SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy
2. RAD001 More Than Doubles Time Without Tumor Growth After Failure of Standard Treatment in Patients With Advanced Kidney Cancer
3. Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments
4. RAD001 Granted Priority Review in the US Based on Potential to Fill Unmet Medical Need in Patients With Advanced Kidney Cancer
5. RAD001 Combined with Sandostatin LAR(R) Depot and as Monotherapy Controls Growth of Rare Pancreatic Neuroendocrine Tumors
6. Latest RAD001 Study Results Show Further Increase in Time Without Tumor Growth in Patients With Advanced Kidney Cancer
7. RAD001 Shows Potential to Reverse Resistance to Herceptin(R)* in Metastatic Breast Cancer Patients, Leading to Phase III Trial
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
10. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
11. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Health 2.0 announces Bernard Tyson , CEO of ... Topol , Patrick Soon-Shiong , and Samsung,s President ... Fall Conference this coming Sept. 21-24 in ... set to host the very first Wearable Tech Fashion Runway ... Tech & Wearables: Powering Healthy Lifestyles. The panel will ...
(Date:7/29/2014)...   , First patient ... efficacy and safety of MSB0010718C in patients with metastatic Merkel ... aggressive skin cancer lacking effective treatments   MSB0010718C is ... clinical trial for the treatment of solid tumors that aims ... a subsidiary of Merck KGaA, Darmstadt, Germany ...
(Date:7/28/2014)... July 28, 2014  Dignity Health St. Mary,s ... the Get With The Guidelines®-Stroke Silver-Plus Quality Achievement ... by the American Heart Association/American Stroke Association for ... number four cause of death and a leading ... United States , according to the American ...
Breaking Medicine Technology:Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 2Dignity Health St. Mary's Medical Center Honored with Quality Achievement Award for Stroke Care 3
... Cephalon, Inc. (Nasdaq: CEPH ) today provided notice ... Notes due 2014 (the "2014 Notes") and 2.00 percent ... in respect of the Merger (as defined below) of ... Industries Ltd., an Israeli corporation ("Parent"), the consummation of ...
... The Plasma Protein Therapeutics Association (PPTA) ... temporary and proposed regulations implementing the ... and fails to take into account concerns expressed ... narrow definition of an "orphan drug" disproportionally affects ...
Cached Medicine Technology:Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015 2Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015 3Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015 4Cephalon Gives Notice of Anticipated Fundamental Change to Holders of Its 2.50% Convertible Senior Subordinated Notes due 2014 and 2.00% Convertible Senior Subordinated Notes due 2015 5IRS Proposed Regulations on Orphan Drug Exclusion from Drug Tax Stand to Harm Future Development of Treatments for Rare Disease Patients 2IRS Proposed Regulations on Orphan Drug Exclusion from Drug Tax Stand to Harm Future Development of Treatments for Rare Disease Patients 3IRS Proposed Regulations on Orphan Drug Exclusion from Drug Tax Stand to Harm Future Development of Treatments for Rare Disease Patients 4
(Date:7/29/2014)... July 29, 2014 July 29, 2014 – ... care, is proud to announce that it is a Bronze ... online video segments; Silverado Through a Child's Eye ... , In Silverado Through a Child's Eye , seven-year-old ... mom at Silverado Beverly Place, a memory care community in ...
(Date:7/29/2014)... 29, 2014 Doug and Sandra Williams have ... and selling their grow-your-own log kits for almost that long. ... diet and a treat for their guests. A new ... to the Lost Creek Mushroom Farm online coverage. , They ... but soon turned to selling the logs instead of the ...
(Date:7/29/2014)... Palm City, Florida (PRWEB) July 29, 2014 ... premier providers of cold therapy products, announced today the ... newly designed hip wrap has been specifically created for ... comfort and enables the patient to enjoy the benefits ... , Hundreds of thousands of hip replacements are ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 This Latest ... Regulations to Practice (2014 Edition) not only provided a ... on clinical trials for imported drug registration but also ... Chinese GCP to guide you to use the Chinese ... in the “post-patent-cliff” world step by step. , The ...
(Date:7/29/2014)... procedure may enable more widespread use of preoperative testing ... with severe sleep apnea, suggests a study in ... and Dr. Jeff E. Mandel of the University of ... control" anesthetic technique for putting patients to sleep briefly-just ... apnea. The simplified technique requires no special expertise and ...
Breaking Medicine News(10 mins):Health News:Silverado Selected a Winner in the 35th Annual Telly Awards for Producing Inspiring Online Video Content 2Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 2Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 3Health News:Lost Creek Mushroom Farm Cooks Up a Company Dish from Shiitake Mushrooms Grown on Logs With Grow-Your-Own Log Kits 4Health News:New IsoComforter Cold Therapy Unit Plus Hip Wrap Gives Post Operative Hip Replacement Patients Faster Recovery Times 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 2Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 3Health News:Pharma Clinical Trials Market in China: Authorities for Drug New Study Now Available at MarketReportsOnline.com 4Health News:New anesthesia technique helps show cause of obstruction in sleep apnea 2Health News:New anesthesia technique helps show cause of obstruction in sleep apnea 3
... radiation, whether due to cancer treatment or multiple diagnostic CT ... for the next 58 years or longer, according to University ... to be the longest of any group of children exposed ... was published in the December 2010 edition of the journal, ...
... , THURSDAY, Dec. 16 (HealthDay News) -- People with acute ... more confident about their diagnosis when they have a CT ... patients underestimate the radiation risk posed by this type of ... patients with abdominal pain not caused by injury. Only 20 ...
... Reporter , THURSDAY, Dec. 16 (HealthDay News) -- Researchers ... -- the part of the brain believed to generate ... improve treatment for post-traumatic stress disorder (PTSD) and other ... confirming that the almond-shaped structure is crucial for triggering ...
... A new U.S. study finds that 75 percent of children ... they consumed, the less they slept. Researchers at the ... than 200 children, aged 5 to 12, during routine clinical ... the types and amounts of snacks consumed by their children ...
... Randy Dotinga HealthDay Reporter , WEDNESDAY, Dec. 15 ... the United States has declined 28 percent since the late ... of all deaths, a new study finds. And the ... for cancer or any other diagnostic group, an estimated $286 ...
... 2010 There is burgeoning public interest in possible ... In a study published in the December 2010 issue ... found that there was no independent association between serum ... mortality in this prospective study, the first in a ...
Cached Medicine News:Health News:Decades after childhood radiation, thyroid cancer a concern 2Health News:ER Patients Put Faith in CT Scans 2Health News:Brain Anomaly Leaves Woman Without Fear 2Health News:Brain Anomaly Leaves Woman Without Fear 3Health News:Death Rate From Heart Disease, Stroke Drops Off Over Decade 2Health News:Death Rate From Heart Disease, Stroke Drops Off Over Decade 3Health News:Vitamin D and parathyroid hormone levels may not affect cardiovascular mortality 2
... for automated bioresearch . The ... offers flexibility, versatility, reliability and ... LS-50B, the LS 55 spectrometer ... accessories and software to address ...
Spectra 5000 is one of the most versatile analytical devices used in conventional laboratories which can work in the ultravoilet and visible range from 200 to 1000 nm for quantitative and qualitative...
... is a new generation Spectrophotometer for ... 320 nm to 1020 nm with ... computer and printer. It features four ... of transmittance, absorption and concentration with ...
... Spectrophotometer is truly a ... instrumentation. The latest electro-optical ... a radically new design, ... performance unprecedented in a ...
Medicine Products: